Bone Biologics (BBLG) Non-Current Assets (2014 - 2019)
Bone Biologics (BBLG) reported Non-Current Assets of $26.0 for Q1 2019, down 78.69% year-over-year from $122.0 in Q1 2018, and down 48.0% quarter-over-quarter from $50.0 in Q4 2018.
Bone Biologics (BBLG) Non-Current Assets (2014 - 2019) Analysis & Trends
Bone Biologics (BBLG) has 6 years of Non-Current Assets data on file, last reported at $26.0 in Q1 2019.
- Non-Current Assets for Q1 2019 came in at $26.0, down 78.69% year-over-year; the trailing twelve-month figure through Dec 2019 was $26.0 (down 92.44% YoY), and the FY2018 annual result was $50.0, down 65.75% from the prior year.
- Non-Current Assets eased to $26.0 in Q1 2019 per BBLG's latest filing, from $50.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $11554.0 in Q1 2015 and troughed at $26.0 in Q1 2019.
- A 5-year average of $2415.3 and a median of $218.0 in 2017 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2016 and 2017: Non-Current Assets sank 97.29% in 2016, then sank 39.67% in 2017.
- A 5-year view of Non-Current Assets shows it stood at $5804.0 in 2015, then plunged by 95.83% to $242.0 in 2016, then slumped by 39.67% to $146.0 in 2017, then plunged by 65.75% to $50.0 in 2018, then plunged by 48.0% to $26.0 in 2019.
- Business Quant data shows BBLG's Non-Current Assets at $26.0 in Q1 2019, $50.0 in Q4 2018, and $74.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 62,953.78 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 39.71 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 26.00 |
| Dec 31, 2018 | 50.00 |
| Sep 30, 2018 | 74.00 |
| Jun 30, 2018 | 98.00 |
| Mar 31, 2018 | 122.00 |
| Dec 31, 2017 | 146.00 |
| Sep 30, 2017 | 170.00 |
| Jun 30, 2017 | 194.00 |
| Mar 31, 2017 | 218.00 |
| Dec 31, 2016 | 242.00 |
| Sep 30, 2016 | 282.00 |
| Jun 30, 2016 | 322.00 |
| Mar 31, 2016 | 362.00 |
| Dec 31, 2015 | 5,804.00 |
| Sep 30, 2015 | 10,413.00 |
| Jun 30, 2015 | 10,983.00 |
| Mar 31, 2015 | 11,554.00 |
| Dec 31, 2014 | 11,621.00 |